Department of Basic Medical Sciences, Faculty of Medicine, University of Ghent, Belgium.
Ann Ist Super Sanita. 2009;45(3):260-4.
The cytokinesis-block micronucleus assay in peripheral blood lymphocytes is a standardised and validated technique for biodosimetry. Automated scoring of micronuclei allows large scale applications as in population triage in case of radiation accidents or malevolent use of radioactive sources. The dose detection limit (95% confidence) of the micronucleus assay for individual dose assessment is restricted to 0.2 Gy but can be decreased to 0.1 Gy by scoring centromeres in micronuclei using fluorescence in situ hybridization (FISH). In the past the micronucleus assay was applied for a number of large scale biomonitoring studies of nuclear power plant workers and hospital workers. Baseline micronucleus frequencies depend strongly on age and gender. The assay was also already used for biodosimetry of radiation accidents. In a multiple endpoint biodosimetry study for dose assessment of a worker exposed accidentally in 2003 to X-rays, a good agreement was obtained between dose estimates resulting from the micronucleus assay, the scoring of dicentrics and translocations. Automated scoring of micronuclei in combination with centromere signals, allowing systematic biodosimetry of exposed populations, remains a challenge for the future.
细胞分裂阻断微核试验在人外周血淋巴细胞中的应用是生物剂量测定的一种标准化和经过验证的技术。微核的自动评分允许大规模应用,例如在辐射事故或恶意使用放射源的情况下进行人群分诊。微核试验的个体剂量评估的剂量检测限(95%置信区间)限制在 0.2 Gy,但通过使用荧光原位杂交(FISH)对微核中的着丝粒进行评分,可将检测限降低至 0.1 Gy。过去,该微核试验已应用于多项大规模的核电站工人和医院工作人员的生物监测研究。微核频率的基线强烈依赖于年龄和性别。该试验也已用于辐射事故的生物剂量测定。在 2003 年一名工人意外受到 X 射线照射的多终点生物剂量测定研究中,微核试验、双着丝粒和易位的评分所产生的剂量估计值之间存在良好的一致性。自动评分微核与着丝粒信号相结合,允许对暴露人群进行系统的生物剂量测定,这仍然是未来的一个挑战。